Matches in Nanopublications for { ?s ?p "[* The majority of patients with vascular disease receive acetylsalicylic acid as an anti-aggregatory agent, which has also been shown to induce a variable response; however, the role of P2Y(12) ADP receptor polymorphisms in the platelet response to acetylsalicylic acid in patients with vascular disease has not yet been studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[* The majority of patients with vascular disease receive acetylsalicylic acid as an anti-aggregatory agent, which has also been shown to induce a variable response; however, the role of P2Y(12) ADP receptor polymorphisms in the platelet response to acetylsalicylic acid in patients with vascular disease has not yet been studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP639791.RAWxBXKsXBgXiRbLpQY4ZjWNw8cJWE_lsg4X-1WYC-yok130_assertion description "[* The majority of patients with vascular disease receive acetylsalicylic acid as an anti-aggregatory agent, which has also been shown to induce a variable response; however, the role of P2Y(12) ADP receptor polymorphisms in the platelet response to acetylsalicylic acid in patients with vascular disease has not yet been studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP639791.RAWxBXKsXBgXiRbLpQY4ZjWNw8cJWE_lsg4X-1WYC-yok130_provenance.
- NP867528.RAHDBlrm7JkmPMkKldJS-VuvXwYEA2nXcnJbXEHutkauo130_assertion description "[* The majority of patients with vascular disease receive acetylsalicylic acid as an anti-aggregatory agent, which has also been shown to induce a variable response; however, the role of P2Y(12) ADP receptor polymorphisms in the platelet response to acetylsalicylic acid in patients with vascular disease has not yet been studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867528.RAHDBlrm7JkmPMkKldJS-VuvXwYEA2nXcnJbXEHutkauo130_provenance.